In GBM, lncRNA HOTAIRM1 (43, 44) and AGAP2-AS1 (45, 46), as oncogenic factors, promoted tumorigenesis, predicted a poor clinical outcome, and were potential biomarkers and therapeutic targets. Here, AGAP2 is linked to glioblastoma.